Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Lipocalin 2 (LCN2) is a secreted protein that belongs to the Lipocalins, a group of transporters of small lipophilic molecules such as steroids, lipopolysaccharides, iron, and fatty acids in circulation. Two decades after its discovery and after a high variety of published findings, LCN2's altered expression has been assigned to critical roles in several pathological organ conditions, including liver injury and steatosis, renal damage, brain injury, cardiomyopathies, muscle-skeletal disorders, lung infection, and cancer in several organs. The significance of this 25-kDa lipocalin molecule has been impressively increased during the last years. Data from several studies indicate the role of LCN2 in physiological conditions as well as in response to cellular stress and injury. LCN2 in the liver shows a protective role in acute and chronic injury models where its expression is highly elevated. Moreover, LCN2 expression is being considered as a potential strong biomarker for pathological conditions, including rheumatic diseases, cancer in human organs, hepatic steatosis, hepatic damage, and inflammation. In this review, we summarize experimental and clinical findings linking LCN2 to the pathogenesis of liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., & Aderem, A. (2004) · Nature · doi:10.1038/nature03104 · Cited by 1,877 · cited 6×
“REVIEW published: 27 September 2016 doi: 10.3389/fphys.2016.00430 Frontiers in Physiology | www.frontiersin.org 1 September 2016 | Volume 7 | Article 430 Edited by: Ghanshyam Upadhyay, City College of New York-CUNY, USA Reviewed by: Michael Hickey, Monash University, Australia Hai Li, Shanghai Jiao Tong University, Ch…”
BackgroundInfluentialGoetz, D. H., Holmes, M. A., Borregaard, N., Bluhm, M. E., Raymond, K. N., & Strong, R. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00708-6 · Cited by 1,355
Epidemiology of Non-Alcoholic Fatty Liver Disease
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026 · cited 2×
“Shortly after, an additional investigation demonstrated that LCN2 levels was Frontiers in Physiology | www.frontiersin.org 11 September 2016 | Volume 7 | Article 430 FIGURE 5 | Elevated hepatic LCN2 expression is a physiological indicator of hepatic inflammation.”
BackgroundA Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake
Devireddy, L. R., Gazin, C., Zhu, X., & Green, M. R. (2005) · Cell · doi:10.1016/j.cell.2005.10.027 · Cited by 672
An Iron Delivery Pathway Mediated by a Lipocalin
Yang, J., Goetz, D., Li, J.-Y., Wang, W., Mori, K., Setlik, D., Du, T., Erdjument-Bromage, H., Tempst, P., Strong, R., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00710-4 · Cited by 651 · cited 2×
“…from Triebel et al. (1992), Kjeldsen et al. (1993), Bundgaard et al. (1994), Axelsson et al. (1995), Garay-Rojas et al. (1996), Cowland and Borregaard (1997), Goetz et al. (2002), Yang et al. (2002), Flo et al. (2004), Cai et al. (2010), Yang et al. (2009), and Asimakopoulou and Weiskirchen (2015).”
BackgroundBerger, T., Togawa, A., Duncan, G. S., Elia, A. J., You-Ten, A., Wakeham, A., Fong, H. E. H., Cheung, C. C., & Mak, T. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510847103 · Cited by 460 · cited 1×
“This assumption was further confirmed in experiments showing that LCN2 has the capacity to limit bacterial growth by sequestering the iron-laden siderophore after infection in mice (Flo et al., 2004; Holmes et al., 2005; Berger et al., 2006).”
BackgroundHuman neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse
Kjeldsen, L., Cowland, J. B., & Borregaard, N. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00152-7 · Cited by 368
Holmes, M. A., Paulsene, W., Jide, X., Ratledge, C., & Strong, R. K. (2005) · Structure · doi:10.1016/j.str.2004.10.009 · Cited by 246
Lipocalin-2 as a therapeutic target for brain injury: an astrocentric perspective
Suk, K. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.08.001 · Cited by 145
Cited by
Effect of ethanol on lipid metabolism
You, M., & Arteel, G. E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.037 · Cited by 354
A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis
Yao, F., Deng, Y., Zhao, Y., Mei, Y., Zhang, Y., Liu, X., Martinez, C., Su, X., Rosato, R. R., Teng, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27452-9 · Cited by 322
NUPR1 is a critical repressor of ferroptosis
Liu, J., Song, X., Kuang, F., Zhang, Q., Xie, Y., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Communications · doi:10.1038/s41467-021-20904-2 · Cited by 290
Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
Hwang, S., Yun, H., Moon, S., Cho, Y. E., & Gao, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.751802 · Cited by 84
Stress increases hepatic release of lipocalin 2 which contributes to anxiety-like behavior in mice
Yan, L., Yang, F., Wang, Y., Shi, L., Wang, M., Yang, D., Wang, W., Jia, Y., So, K.-F., & Zhang, L. (2024) · Nature Communications · doi:10.1038/s41467-024-47266-9 · Cited by 63
“In peripheral organs, LCN2 plays crucial roles, as it is related to hepatic 16 or kidney 45 malfunction under acute and chronic injury and regulates metabolic in fl ammation in intestinal tissues 46 .”
Metadata
- Authors
- Asimakopoulou, A., Weiskirchen, S., & Weiskirchen, R.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2016-09-27
- Volume
- 7
- Pages
- 430-430
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W2526007018
- Cited by
- 116
- References
- 12
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy. https://app.cochat.ai/papers/10.3389/fphys.2016.00430
- The paper
- Asimakopoulou, A., Weiskirchen, S., & Weiskirchen, R. (2016). Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy. Frontiers in Physiology. https://doi.org/10.3389/fphys.2016.00430
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.